Study of the Epidemiological, Clinical, Diagnostic, and Therapeutic Characteristics of Gastric Cancers in Algeria

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

• Ages 19 years and older
• All sexes
• No healthy volunteers
• Adult, Older adult

Study population: Patients with histologically confirmed gastric cancer, followed in the participating oncology departments.

Trial locations and contacts

15 sites in 1 country. Contact the study team or a site near you to ask about taking part.

About this study

Conditions

Gastric Cancer, Gastric (Stomach) Cancer, Gastric Cancer (Diagnosis)

Keywords

Gastric Cancer, Gastric cancer in Algerian patients, Observational study, Patient outcomes, Oncology, Retrospective data, Treatment strategies, Diagnostic approaches, Clinical characteristics, Epidemiological data, Demographic data, Cross-sectional study, Real-world data, Algeria, Algerian Study

Medical subject headings

Stomach Neoplasms, Disease, Neoplasms

What is being measured

The primary outcome is the main question the study is designed to answer.

1. Demographic characteristics of patients with gastric cancer in Algeria

   The patient's demographic profile will include age (years) and sex. Body Mass Index (BMI) will be calculated using weight (kg) and height (m) according to the formula BMI = weight / height² (kg/m²).

   Measured: At Baseline ( Initial visit )

2. Sociological characteristics of patients with gastric cancer in Algeria

   The patient's sociological profile will be described as a composite variable : Education level (primary, secondary, university, other), Profession (employed, unemployed, retired, student, other), Place of residence (current residence; urban or rural), Origin (wilaya of birth/origin)

   Measured: At Baseline ( Initial visit )

3. Epidemiological characteristics of patients with gastric cancer in Algeria.

   Frequency (%) of epidemiological risk factors including family history of cancer, Helicobacter pylori infection, smoking status, alcohol consumption, dietary habits, and exposure to chemical substances.

   Measured: At Baseline (Initial Visit)

4. Clinical characteristics of patients with gastric cancer in Algeria.

   Distribution of patients according to initial symptoms, tumor localization, histological characteristics, biomarker expression, presence of metastases, and tumor stage according to the AJCC classification.

   Measured: At Basline ( Initial Visit)

5. Evolutionary characteristics of patients with gastric cancer.

   Distribution of treatment modalities including surgery (palliative or curative) and chemotherapy (adjuvant or treatment lines), as well as treatment response, complications, disease-free survival (DFS), and duration of response.

   Measured: At Baseline ( Initial Visit)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

1. First posted18 Mar 2026
2. Study start5 Aug 2025
3. Primary completion5 Aug 2026 (estimated)
4. Study completion5 Aug 2026 (estimated)

Resources

• Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
• Other trials for Gastric CancerStudies of the same condition, open and under way.
• What the trial phases meanHow a treatment moves from first tests in people to approval.

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.